SMAD2 and esophageal adenocarcinoma: For SMAD4, about 70% of esophageal adenocarcinoma (EAC) associated with Barrett’s esophagus (BE) revealed loss of heterozygosity in a region involving SMAD2 and SMAD4 on chromosome 18q [42,43].